Mon. May 25th, 2026
Spread the love

Paige Bueckers has been named the WNBA’s Rookie of the Year, the league announced on Tuesday morning. Bueckers, a Dallas Wings guard who was the No. 1 overall pick, averaged 19.2 points, 5.4 assists, and 3.9 rebounds in her rookie campaign.

Bueckers received 70 of 72 media votes for the award, with Washington Mystics guard Sonia Citron earning the other two votes. Media voting is anonymous, so the league does not share the exact list of voters, nor where they landed.

Citron averaged 14.9 points, 4 rebounds, and 2.4 assists in her first WNBA season.

I, SB Nation’s senior WNBA writer and one of 72 media voters, selected Bueckers for Rookie of the Year, as explained in an article posted last week:

After years in the public eye, Paige Bueckers entered the WNBA with sky-high expectations, as a consensus No. 1 pick fresh off a national title.

And, five months removed from draft night, it’s safe to say that Bueckers has exceeded all of those expectations, save for team success.

This season, Bueckers has averaged 19.1 points, 5.3 assists, 3.8 rebounds, and 1.6 steals per game. Her scoring average is the 7th-highest in WNBA history among rookies, and the 5th-highest in the WNBA this season.

Her 56% true shooting (which accounts for two-point and three-point shots as well as free throws) is higher than veteran WNBA guards like Sabrina Ionescu, Skylar Diggins, and Courtney Williams, among dozens of others.

While she’s struggled from downtown (Bueckers is shooting 32.2% from three, a significant dip from her strong 42.3% three-point average in college), she’s been efficient from everywhere else, shooting 51.3% from two-point range and 89.7% from the line.

It’s incredibly unusual to come in as a highly-touted rookie guard, carry the offensive load, and be efficient while doing so; Kelsey Plum, who was the NCAA’s all-time leading scorer when she was drafted, averaged 8.5 points on 34.6% shooting as a rookie. Sabrina Ionescu missed most of her rookie season with an ankle sprain, but averaged 11.7 points on 37.9% shooting in her subsequent first full season.

Bueckers’ 19.1 points on 47.4% shooting blows those seasons out of the water.

Last month, Bueckers tied the WNBA record for most points in a single game by a rookie, exploding for 44 points on 17-21 shooting. Before Bueckers, no WNBA player has ever taken more than 20 shots in a game and missed four or fewer.

Sonia Citron’s case for Rookie of the Year

Citron had a case as well, largely hinging on the fact that she was more efficient and on a team that won more games. She shot 44.5% from three on the season — the highest among WNBA guards — and scored the most points ever by a Mystics player in a single season:

Still, when it came time to cast my ballot, Bueckers was my clear choice.

Part of the edge goes to Bueckers simply because of the load she’s had to carry; the UConn product has a 24.9% usage rate this season, meaning that about a quarter of all possessions when she’s on the floor end with her (either taking/making a shot or turning the ball over).

Part of the edge goes to Bueckers due to her playmaking; the Wings rookie is averaging the 10th-most assists per game this season. She has the 11th-highest assist percentage this season (29.4% of Wings players’ field goals are assisted by Bueckers while she’s on the floor). And, she has the 8th-best assist-to-turnover ratio in the league (among those averaging at least two dimes per game).

Several advanced statistics (imperfectly) measure a player’s individual impact, and Bueckers leads in those categories.

Bueckers has the 9th-highest PER in the league (21.4), while Citron has a 16.5 PER, which is just above league average (15). (Player Efficiency Rating measures a player’s statistical contributions per minute into a single, pace-adjusted number, accounting for positive actions like points, assists, and rebounds, as well as negative actions like turnovers and missed shots).

Bueckers also leads Citron in another advanced analytics, PIE, which shows the percentage of game events a player achieved (based on a complex formula that is basically a revamped version of PER). Bueckers has a 14.2 PIE rating (16th-best in the league), while Citron has an 11.9 PIE (38th-best).

How insightful are these statistics? It’s an age-old question, but the eye test affirms Bueckers’ impact.

Had the Mystics had a stronger finish to the season — and perhaps even secured a spot in the playoffs — Citron’s case would be made more compelling. For much of the season, the gap between the Mystics’ and the Wings’ records was larger and helped Citron’s Rookie of the Year case alive.

But the gap between the two teams’ success is not substantial enough to overcome the fact that Bueckers has carried a heavier load on her team, and by most metrics, has been the more impactful, all-around player.

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.